Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomas. Losi G, Mussetti A, Pena M, Lopez-Pereira P, et al. Bone Marrow Transplant 2025;60:259-269.

Read + Share

Amedeo Smart

Independent Medical Education

Losi G, Mussetti A, Pena M, Lopez-Pereira P, et al. Anti-CD19 CAR T-cell therapy for primary and secondary CNS lymphomas. Bone Marrow Transplant 2025;60:259-269.
PMID: 39674850